Multinational drugmakers are exploring wider opportunities in Ghana. Access to regional markets and a comparativelywell-established drug regulatory body bodes well for foreign drugmakers. The bureaucratic environment has led to difficulties doingbusiness, including high operational costs for foreign companies. While Ghana is positioned as one of the more attractivepharmaceutical markets for multinational firms on a regional basis, generic products will maintain a dominant share of the market,somewhat limiting high-value commercial opportunities.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook